Status:
UNKNOWN
Iliac Vein Stenting and Compression Therapy in Recurrent Venous Ulceration
Lead Sponsor:
Assiut University
Conditions:
Venous Ulcer Recurrent
Eligibility:
All Genders
12-75 years
Brief Summary
Comparing the result of of iliac vein stenting and compression therapy in management of recurrent venous ulceration.
Detailed Description
Venous ulceration is the most common etiology of lower extremity ulceration, approximately affecting almost 1% of the world's population. although its overall prevalence is relatively low, the refract...
Eligibility Criteria
Inclusion
- iliac vein compression.
- competent superficial venous system.
- isolated iliac vein lesion.
- patent femoropopliteal segment.
- ulcers located in the gaiter area.
- age \> 12 years
- patients with ulcers located in the gaiter area, along with the following associated symptoms: leg heaviness, pain, varicose veins, edema, hemosedrin staining, pruritus, venous dermatitis, lipodermatoscelrosis, telangiectasias, corona phlebectatica, atrophie blanche and deformity of the leg.
Exclusion
- patients with arterial disease in the same limb.
- patients with history of phlebitis.
- patients with congenital venous malformation
- patients with malignancy.
- patients with raised renal chemistry.
- patients with skin allergy.
- diabetic neuropathic ulcer.
- atypical site of venous ulcer.
- acute onset DVT.
- age \< 12 years.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04834232
Start Date
May 1 2021
End Date
December 1 2021
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine
Asyut, Egypt, 71515